Advertisement

Retinoblastoma: Staging and Grouping

Chapter

Abstract

A commonly used tumor classification is essential in order to plan initial treatment, determine prognosis, assess treatment response, compare outcomes, and plan clinical trials. Berman maintains that for tumor classifications to be successful, they must reflect clinical reality and must be changed as information is accrued. Almost never does the staging of the tumor rest solely with the subspecialty surgeon. It usually results from interaction between pathologists and oncologists. In almost all solid childhood malignancies, except retinoblastoma, survival of the patient is the sole end point against which to assess treatment efficacy and side effects.

Keywords

Subretinal Fluid Intraocular Tumor Anchorage Independence Assess Treatment Efficacy Laser Consolidation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Fleming I. Staging of pediatric cancers: problems in the development of a national system. Semin Surg Oncol. 1992;8(2):94–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Berman JJ. Tumor classification: molecular analysis meets Aristotle. BMC Cancer. 2004;4:10.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Reese A, Ellsworth R. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol. 1963;67:164–72.PubMedGoogle Scholar
  4. 4.
    Ellsworth RM. The practical management of retinoblastoma. Trans Am Ophthalmol Soc. 1969;67:462–534.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Pratt CB, Fontanesi J, Lu X, et al. Proposal for a new staging scheme for intraocular and extraocular retinoblastoma based on an analysis of 103 globes. Oncologist. 1997;2(1):1–5.PubMedGoogle Scholar
  6. 6.
    AJCC. Retinoblastoma. 6th ed. New York: Springer; 2002.Google Scholar
  7. 7.
    Wolff J, Boesel C, Ellsworth R. Extraocular retinoblastoma. Childrens Cancer Study Group Protocol CCSG 962. 1978.Google Scholar
  8. 8.
    Grabowski E, Abramson DH. Intraocular and extraocular retinoblastoma. Hematol Oncol Clin N Am. 1978;1:721–35.Google Scholar
  9. 9.
    Stannard C, Sealy R, Hering E, et al. Postenucleation orbits in retinoblastoma: treatment with 125I brachytherapy. Int J Radiat Oncol Biol Phys. 2002;54(5):1446–54.PubMedCrossRefGoogle Scholar
  10. 10.
    Kivela T, Kujala E. Prognostication in eye cancer: the latest tumor, node, metastasis classification and beyond. Eye (Lond). 2013;27(2):243–52.CrossRefGoogle Scholar
  11. 11.
    Chantada G, Doz F, Antoneli CB, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer. 2006;47(6):801–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Chantada GL, Sampor C, Bosaleh A, et al. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients. JAMA Ophthalmol. 2013;131(9):1127–34.PubMedCrossRefGoogle Scholar
  13. 13.
    Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133(8):1199–202.PubMedGoogle Scholar
  14. 14.
    de Graaf P, Goricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42(1):2–14.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Murphree AL. The case for a new group classification of intraocular retinoblastoma. Ophthalmol Clin North Am. 2005;18:41–53.CrossRefGoogle Scholar
  16. 16.
    Novetsky DE, Abramson DH, Kim JW, Dunkel IJ. Published international classification of retinoblastoma (ICRB) definitions contain inconsistencies – an analysis of impact. Ophthalmic Genet. 2009;30(1):40–4.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Department of Ophthalmology and PediatricsKeck School of Medicine, University of Southern CaliforniaLos AngelesUSA
  2. 2.Retinoblastoma ProgramChildrens Hospital Los AngelesLos AngelesUSA
  3. 3.Hemato-oncology DepartmentHospital JP GarrahanBuenos AiresArgentina

Personalised recommendations